PET Imaging of Steroid Hormone Receptor Expression

Steroid hormone receptor (SHR) expression and changes in SHR expression compared to basal levels, whether upregulated, down-regulated, or mutated, form a distinguishing feature of some breast, ovarian, and prostate cancers. These receptors act to induce tumor proliferation. In the imaging context, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Louis Allott, Graham Smith, Eric O. Aboagye, Laurence Carroll
Format: Article
Language:English
Published: SAGE Publishing 2015-10-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2015.00026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561795838345216
author Louis Allott
Graham Smith
Eric O. Aboagye
Laurence Carroll
author_facet Louis Allott
Graham Smith
Eric O. Aboagye
Laurence Carroll
author_sort Louis Allott
collection DOAJ
description Steroid hormone receptor (SHR) expression and changes in SHR expression compared to basal levels, whether upregulated, down-regulated, or mutated, form a distinguishing feature of some breast, ovarian, and prostate cancers. These receptors act to induce tumor proliferation. In the imaging context, total expression together with modulation of expression can yield predictive and prognostic information. Currently, biopsy for histologic assessment of SHR expression is routine for breast and prostate cancer; however, the technique is not well suited to the heterogeneous tumor environment and can lead to incorrect receptor expression assignment, which precludes effective treatment. The development of positron emission tomography (PET) radioligands to image receptor expression may overcome the difficulties associated with tumor heterogeneity and facilitate the assessment of metastatic disease.
format Article
id doaj-art-a1abe55c2f0743a78cab6d065ba8083e
institution Kabale University
issn 1536-0121
language English
publishDate 2015-10-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-a1abe55c2f0743a78cab6d065ba8083e2025-01-03T01:24:46ZengSAGE PublishingMolecular Imaging1536-01212015-10-011410.2310/7290.2015.0002610.2310_7290.2015.00026PET Imaging of Steroid Hormone Receptor ExpressionLouis AllottGraham SmithEric O. AboagyeLaurence CarrollSteroid hormone receptor (SHR) expression and changes in SHR expression compared to basal levels, whether upregulated, down-regulated, or mutated, form a distinguishing feature of some breast, ovarian, and prostate cancers. These receptors act to induce tumor proliferation. In the imaging context, total expression together with modulation of expression can yield predictive and prognostic information. Currently, biopsy for histologic assessment of SHR expression is routine for breast and prostate cancer; however, the technique is not well suited to the heterogeneous tumor environment and can lead to incorrect receptor expression assignment, which precludes effective treatment. The development of positron emission tomography (PET) radioligands to image receptor expression may overcome the difficulties associated with tumor heterogeneity and facilitate the assessment of metastatic disease.https://doi.org/10.2310/7290.2015.00026
spellingShingle Louis Allott
Graham Smith
Eric O. Aboagye
Laurence Carroll
PET Imaging of Steroid Hormone Receptor Expression
Molecular Imaging
title PET Imaging of Steroid Hormone Receptor Expression
title_full PET Imaging of Steroid Hormone Receptor Expression
title_fullStr PET Imaging of Steroid Hormone Receptor Expression
title_full_unstemmed PET Imaging of Steroid Hormone Receptor Expression
title_short PET Imaging of Steroid Hormone Receptor Expression
title_sort pet imaging of steroid hormone receptor expression
url https://doi.org/10.2310/7290.2015.00026
work_keys_str_mv AT louisallott petimagingofsteroidhormonereceptorexpression
AT grahamsmith petimagingofsteroidhormonereceptorexpression
AT ericoaboagye petimagingofsteroidhormonereceptorexpression
AT laurencecarroll petimagingofsteroidhormonereceptorexpression